U.S. Pharma Stock News

Kirby (KEX) is back in focus after reporting fourth quarter revenue of US$851.78 million and net income of US$91.81 million, alongside an update on its long running share repurchase program. See our latest analysis for Kirby. The latest earnings and ongoing buybacks come after a strong 90 day share price return of 8.98% and a 1 year total shareholder return of 11.90%, with 3 and 5 year total shareholder returns of 64.86% and 97.51%. This suggests longer term momentum has been stronger than...

Okta (OKTA) shares are back in focus after the company expanded its relationship with the PGA of America, a move that ties its identity platform directly to fan and member digital experiences. See our latest analysis for Okta. Those PGA and AI security headlines arrive at a time when Okta’s short term share price performance has been mixed, with a 30 day share price return of a 4.39% decline and a 90 day share price return of a 3.04% gain. Over a longer horizon, the 1 year total shareholder...

Coinbase Global (NasdaqGS:COIN) is expanding its continuous threat intelligence sharing with Crypto ISAC. The integration automates and broadens distribution of actionable cyber threat data across the blockchain sector. The initiative is designed to support industry-wide defense against sophisticated attacks while protecting user privacy. For you as an investor looking at NasdaqGS:COIN, this move sits at the intersection of crypto trading, custody and cybersecurity. Coinbase operates as a...

Doximity (DOCS) is back in focus after its latest quarter topped internal guidance. Management highlighted growing use of its AI tools by clinicians, and the company paired cautious revenue guidance with a fresh share repurchase authorization. See our latest analysis for Doximity. Despite the better than expected quarter and new AI tools, the share price has been under pressure, with a 30 day share price return of 37.2% and a 1 year total shareholder return of 66.9%, suggesting sentiment has...

Dow Inc. has reported past fourth-quarter 2025 sales of US$9,460 million, down from US$10,405 million a year earlier, and moved from a small prior-year loss to a much larger net loss of US$1,543 million, while completing a share repurchase of 38,539,462 shares for US$2,069.24 million under its April 2022 program. For full-year 2025, Dow’s sales fell to US$39.97 billion from US$42.96 billion and it shifted from prior-year net income of US$1,116 million to a net loss of US$2,623 million,...

Lennox International (NYSE:LII) has completed a new share repurchase tranche, buying back nearly 0.85% of its shares in the most recent quarter. This brings total buybacks under the long running program to almost 40% of the company’s outstanding shares. The latest activity reflects an ongoing focus on returning capital to shareholders through repurchases. For investors watching NYSE:LII, the scale of the buyback program is now a core part of the story. The stock closed at $529.29, with...

If you are wondering whether Progyny's current share price reflects its true worth, this article walks through what the numbers are really saying about the stock. After closing at US$21.65, the shares have seen recent pressure, with returns of a 10.6% decline over 7 days, 19.8% decline over 30 days, 15.9% decline year to date, 3.1% decline over 1 year, 32.9% decline over 3 years, and 57.0% decline over 5 years. These moves come against a backdrop of ongoing interest in fertility benefits and...

Northrop Grumman (NYSE:NOC) is facing U.S. Army penalties linked to significant delays in artillery ammunition deliveries destined for Ukraine. Separately, the company secured a large contract to provide advanced aircraft components to Japan, expanding its international defense presence. For a company like Northrop Grumman, which sits at the center of U.S. and allied defense procurement, this mix of pressure and opportunity is important. The potential U.S. Army penalties highlight...

ITT (ITT) is back in focus after reporting Q4 2025 results that topped expectations, issuing upbeat guidance for early 2026, raising its quarterly dividend by 10%, and advancing the pending SPX FLOW acquisition. See our latest analysis for ITT. ITT shares have been volatile around the results, with a 1-day share price return of a 2.9% decline, a 7-day gain of 8.06%, and a year-to-date share price return of 15.31%. Over the longer term, total shareholder returns of 37.47% over 1 year and...

In the past year, Liberty Broadband reported a net loss of US$2,676 million for 2025, compared with net income of US$869 million in 2024, while also completing a long-running share repurchase totaling 58,804,650 shares for US$8,115.32 million under its 2016 authorization. This sharp swing from profit to loss, alongside the conclusion of a very large multi-year buyback, raises important questions about how Liberty Broadband balances capital returns with earnings quality. With recent share...

D-Wave Quantum (NYSE:QBTS) has acquired Quantum Circuits Inc., adding gate-model technology to its existing annealing systems. The company is adopting a dual-platform approach and expanding in the U.S. with a new headquarters and R&D hub in Boca Raton, Florida. D-Wave entered a $20 million deployment partnership with Florida Atlantic University and a $10 million QCaaS agreement with a Fortune 100 client. New collaborations include work with Davidson Technologies and Anduril Industries to...

Kaspi.kz context and recent share performance Kaspi.kz (KSPI) has been drawing investor attention after recent trading, with the stock last closing at US$76.36 and showing mixed returns over the past month and past 3 months. See our latest analysis for Kaspi.kz. That recent 3.48% 1 day share price gain comes after a softer patch, with a 30 day share price return of 6.7% decline and a 1 year total shareholder return of 21.15% decline. This suggests momentum has cooled after earlier multi year...

Oklo (NYSE:OKLO) has been awarded a U.S. Department of Energy grant to study radioactive materials in hot liquid salt. The project supports development of what is planned to be the first U.S. nuclear fuel recycling facility in Tennessee. The facility is intended to recycle used nuclear fuel into fuel for advanced reactors, with potential implications for nuclear sustainability in the U.S. For you as an investor, this grant places fresh attention on Oklo's role in advanced nuclear technology...

Coca-Cola (NYSE:KO) is facing fresh pressure on its long-used pricing power as volume growth slows and turns negative in several key markets. The company is leaning more on premium, health-oriented products, including brands such as Fairlife milk, to respond to changing consumer preferences. Coca-Cola's CEO has flagged a resumption of bolt-on mergers and acquisitions as part of a wider plan to adjust the group’s growth approach. Coca-Cola, the global beverages group behind its namesake soda...

Summit Therapeutics Inc. previously announced that the FDA accepted for filing its Biologics License Application for ivonescimab plus chemotherapy in EGFR‑mutated, locally advanced or metastatic non-squamous NSCLC after tyrosine kinase inhibitor therapy, assigning a PDUFA action date of November 14, 2026. Beyond this U.S. filing, Summit and partner Akeso have broadened ivonescimab’s late-stage program across multiple Phase III trials and tumor types, underscoring a concerted push to position...

XPeng has launched smart charging payment services in Hong Kong through a global partnership with Antom. The rollout introduces a unified system that supports multiple local payment methods for EV charging. The service is designed to simplify cross border charging payments for XPeng drivers and other EV users. XPeng (NYSE:XPEV), trading at around $17.54, is adding this smart charging payment launch to a period of mixed share performance, with the stock up 6.4% over the past week but lower...

Dividend affirmation and earnings catalyst Zoetis (ZTS) has reaffirmed its shareholder return plans with a second quarter 2026 dividend of $0.53 per share, while investors watch the upcoming February 12 earnings and guidance for signals on future performance. See our latest analysis for Zoetis. Zoetis shares trade at $127.30, with a 90 day share price return of 5.98% contrasting with a 1 year total shareholder return decline of 24.87%. This suggests recent momentum has not yet translated into...

Mettler-Toledo International (NYSE:MTD) reported strong Q4 results, with broad-based growth across regions and product lines. The company reached US$1b in annual service revenue for the first time, marking a key milestone in its service business. Management highlighted continued progress in automation and digitalization initiatives, alongside expansion in emerging markets and high-growth segments. Results came despite ongoing headwinds from tariffs and currency movements. Mettler-Toledo...

Onto Innovation recently advanced toward shipping and qualifying its flagship Dragonfly 5 system for TSMC and announced plans to acquire Semilab, a move expected to enhance its materials characterization and wafer contamination monitoring capabilities. This combination of a high‑end tool qualification with a leading foundry and an accretive acquisition could materially reshape Onto Innovation’s competitive position and profitability profile within semiconductor process control. We’ll now...

In January 2026, Nova Ltd. announced that global leaders in Memory and Logic device production adopted its Nova Metrion platform for Gate-All-Around and advanced DRAM manufacturing, using its fully automated inline Secondary Ion Mass Spectrometry system to improve performance and yield. This adoption expands Nova’s materials metrology presence directly inside advanced fabs, moving high‑precision chemical depth profiling from offline labs into real‑time production control. We’ll now examine...

Biogen (NasdaqGS:BIIB) reports strong commercial performance for Alzheimer’s treatment Leqembi, reflected in collaboration revenues and in market sales. The US FDA grants Breakthrough Therapy Designation to litifilimab for cutaneous lupus erythematosus, marking a key step in Biogen’s immunology efforts. Biogen announces promising clinical results for a high dose SPINRAZA regimen for spinal muscular atrophy, with regulatory review ongoing in the US and approvals already in the EU and...

Why BWX Technologies stock is back in focus BWX Technologies (BWXT) is in the spotlight as investors weigh upcoming fourth quarter earnings expectations alongside fresh digital initiatives, including a new Florida Digital Center and a leadership change in the chief digital officer role. See our latest analysis for BWX Technologies. BWX Technologies’ recent digital expansion in Florida and the appointment of a new chief digital officer come as the shares trade at $203.0, with an 11.63%...

Why GameStop Is Back in Focus for Investors GameStop (GME) is back on many watchlists after recent trading left the stock with a mix of short term losses and gains, prompting investors to reassess what is currently priced in. See our latest analysis for GameStop. Recent trading has been choppy, with a 1-day share price return of 1.36% decline and a 7-day share price return of 4.68% decline. However, the 30-day and year to date share price returns of 16.06% and 19.50% suggest momentum has been...

In early February 2026, Radware launched its Agentic AI Protection Solution, expanding its platform into AI security with real-time behavioral defenses against agent-specific risks such as prompt injection, tool abuse, human–agent trust exploitation, and unauthorized data access. By aligning with the OWASP Top 10 for Agentic AI and integrating a dynamic Risk Graph Map, Radware is positioning this solution as a comprehensive framework for assessing and managing complex multi-agent AI...